Pharma Mar | PHM - Current Liabilities

Stock Price
78.75
Daily Change
-0.45 -0.57%
Monthly
3.01%
Yearly
-12.26%
Q1 Forecast
76.50

Pharma Mar reported EUR93.88M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Almirall EUR 350.64M 52.12M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025